17-ketosteroids and androstan-17-one

17-ketosteroids has been researched along with androstan-17-one* in 1 studies

Other Studies

1 other study(ies) available for 17-ketosteroids and androstan-17-one

Article	Year
Control of obesity in Avy/a mice by 5alpha-androstan-17-one. Experientia, 1978, Dec-15, Volume: 34, Issue:12 Treating VY/WfL-Avy/a mice with 5 alpha-androston-17-one, a mammalian glucose-6-phosphate dehydrogenase inhibitor, prevented the mice from becoming obese. The weight difference between treated and control Avy/a mice was mainly due to a decreased accumulation of triacylglycerol. The compound did not suppress appetite, had no detectable toxicity and did not affect the lipogenesis rates in the liver and carcass. The weight-controlling effect of 5alpha-androstan-17-one in Avy/a mice was reversible upon withdrawal of treatment. Topics: 17-Ketosteroids; Androstanes; Animals; Female; Glucosephosphate Dehydrogenase; Liver; Male; Mice; Mice, Inbred A; Obesity; Triglycerides	1978

Article

Year

Control of obesity in Avy/a mice by 5alpha-androstan-17-one.

Experientia, 1978, Dec-15, Volume: 34, Issue:12

Treating VY/WfL-Avy/a mice with 5 alpha-androston-17-one, a mammalian glucose-6-phosphate dehydrogenase inhibitor, prevented the mice from becoming obese. The weight difference between treated and control Avy/a mice was mainly due to a decreased accumulation of triacylglycerol. The compound did not suppress appetite, had no detectable toxicity and did not affect the lipogenesis rates in the liver and carcass. The weight-controlling effect of 5alpha-androstan-17-one in Avy/a mice was reversible upon withdrawal of treatment.

Topics: 17-Ketosteroids; Androstanes; Animals; Female; Glucosephosphate Dehydrogenase; Liver; Male; Mice; Mice, Inbred A; Obesity; Triglycerides

1978